GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
124 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 59 increasing their positions, 37 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
124
Holding in Top 10
2
Calls
$401K
Puts
–
Top Buyers
| 1 | +$6.61M | |
| 2 | +$3.47M | |
| 3 | +$2.94M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.69M |
| 5 |
Renaissance Technologies
New York
|
+$2.61M |
Top Sellers
| 1 | -$5.61M | |
| 2 | -$4.78M | |
| 3 | -$4.74M | |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$4.04M |
| 5 |
Two Sigma Investments
New York
|
-$3.2M |